Isonea Limited

isonea ltd (asx:isn; otcqx:isoay) is developing innovative, non-invasive devices and mobile health applications using acoustic respiratory monitoring (arm™), to improve the management of costly, chronic respiratory disorders such as asthma and chronic obstructive pulmonary disease (copd). by combining this proprietary technology with its asthmasense™ mobile apps and universally available smartphones, isonea enables anyone, anywhere, at any time to monitor breathing distress symptoms, in order to take action and improve personal outcomes. isonea’s core arm™ technology has produced 3 devices that have received clearance from the u.s. fda, the european union ce, and the australian tga.